Showing Results for
- Academic Journals (7)
Search Results
- 7
Academic Journals
- 7
- Search Terms:
- 1From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): T Hara [1, 2]; A Kume [1]; Y Hanazono [3]; H Mizukami [1]; T Okada [1]; H Tsurumi [2]; H Moriwaki [2]; Y Ueda [4]; M Hasegawa [4]; K Ozawa [1, 5] Gene transfer to hematopoietic stem cells (HSCs) holds...
- 2From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): D J Wells [1] In brief Progress * Plasmid-based gene transfer has advantages compared to the use of viral vectors. * Application of an electrical field dramatically enhances plasmid gene transfer...
- 3From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedAuthor(s): D M Kofler [1, 3, 4, 5]; H Büning [4]; C Mayr [1]; D Bund [1]; J Baumert [2]; M Hallek [1, 3, 4, 5]; C-M Wendtner [1, 3, 4, 5] B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the abnormal...
- 4From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedDevelopment of novel therapeutic agents is needed to address the problems of locally recurrent, metastatic, and advanced hormone-refractory prostate cancer. We have constructed a novel complex adenovirus (Ad) vector...
- 5From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedGene transfer complexes containing poly-L-lysine (poly-K) and DNA with ligands directed at the serpin enzyme complex receptor (sec-R) deliver reporter genes to receptor-bearing cells in vivo. Expression lasts for about...
- 6From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedThe immunogenicity of adenovirus (Ad) vectors is enhanced by virus-specific memory immune responses present in most individuals as a result of past exposure to these ubiquitous pathogens. We previously identified the...
- 7From: Gene Therapy. (Vol. 11, Issue 18) Peer-ReviewedAs small molecule drugs for Duchenne muscular dystrophy (DMD), antisense oligonucleotides (AONs) have been shown to restore the disrupted reading frame of DMD transcripts by inducing specific exon skipping. This allows...